304 related articles for article (PubMed ID: 15382060)
41. Expression of KIT and PDGFR is associated with a good prognosis in neuroblastoma.
Shimada A; Hirato J; Kuroiwa M; Kikuchi A; Hanada R; Wakai K; Hayashi Y
Pediatr Blood Cancer; 2008 Feb; 50(2):213-7. PubMed ID: 17941064
[TBL] [Abstract][Full Text] [Related]
42. The calcium-sensing receptor and parathyroid hormone-related protein are expressed in differentiated, favorable neuroblastic tumors.
de Torres C; Beleta H; Díaz R; Toran N; Rodríguez E; Lavarino C; García I; Acosta S; Suñol M; Mora J
Cancer; 2009 Jun; 115(12):2792-803. PubMed ID: 19350667
[TBL] [Abstract][Full Text] [Related]
43. L1 is associated with favorable outcome in neuroblastomas in contrast to adult tumors.
Wachowiak R; Fiegel HC; Kaifi JT; Quaas A; Krickhahn A; Schurr PG; Erttmann R; Schachner M; Kluth D; Sauter G; Izbicki JR
Ann Surg Oncol; 2007 Dec; 14(12):3575-80. PubMed ID: 17917782
[TBL] [Abstract][Full Text] [Related]
44. Structural basis of tubulin tyrosination by tubulin tyrosine ligase.
Prota AE; Magiera MM; Kuijpers M; Bargsten K; Frey D; Wieser M; Jaussi R; Hoogenraad CC; Kammerer RA; Janke C; Steinmetz MO
J Cell Biol; 2013 Feb; 200(3):259-70. PubMed ID: 23358242
[TBL] [Abstract][Full Text] [Related]
45. Tubulin tyrosine ligase: protein and mRNA expression in developing rat skeletal muscle.
Arregui CO; Mas CR; Argaraña CE; Barra HS
Dev Growth Differ; 1997 Apr; 39(2):167-78. PubMed ID: 9108330
[TBL] [Abstract][Full Text] [Related]
46. Transcription factor activating protein 2 beta (TFAP2B) mediates noradrenergic neuronal differentiation in neuroblastoma.
Ikram F; Ackermann S; Kahlert Y; Volland R; Roels F; Engesser A; Hertwig F; Kocak H; Hero B; Dreidax D; Henrich KO; Berthold F; Nürnberg P; Westermann F; Fischer M
Mol Oncol; 2016 Feb; 10(2):344-59. PubMed ID: 26598443
[TBL] [Abstract][Full Text] [Related]
47. Posttranslational nitrotyrosination of alpha-tubulin induces cell cycle arrest and inhibits proliferation of vascular smooth muscle cells.
Phung AD; Soucek K; Kubala L; Harper RW; Chloë Bulinski J; Eiserich JP
Eur J Cell Biol; 2006 Dec; 85(12):1241-52. PubMed ID: 17118269
[TBL] [Abstract][Full Text] [Related]
48. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas.
Eggert A; Ikegaki N; Kwiatkowski J; Zhao H; Brodeur GM; Himelstein BP
Clin Cancer Res; 2000 May; 6(5):1900-8. PubMed ID: 10815914
[TBL] [Abstract][Full Text] [Related]
49. Ultrastructural colocalization of tyrosinated and detyrosinated alpha-tubulin in interphase and mitotic cells.
Geuens G; Gundersen GG; Nuydens R; Cornelissen F; Bulinski JC; DeBrabander M
J Cell Biol; 1986 Nov; 103(5):1883-93. PubMed ID: 3782287
[TBL] [Abstract][Full Text] [Related]
50. Assembly and colchicine binding characteristics of tubulin with maximally tyrosinated and detyrosinated alpha-tubulins.
Skoufias DA; Wilson L
Arch Biochem Biophys; 1998 Mar; 351(1):115-22. PubMed ID: 9500839
[TBL] [Abstract][Full Text] [Related]
51. Prediction of clinical outcome and biological characterization of neuroblastoma by expression profiling.
Schramm A; Schulte JH; Klein-Hitpass L; Havers W; Sieverts H; Berwanger B; Christiansen H; Warnat P; Brors B; Eils J; Eils R; Eggert A
Oncogene; 2005 Nov; 24(53):7902-12. PubMed ID: 16103881
[TBL] [Abstract][Full Text] [Related]
52. Expression of TrkC in favorable human neuroblastomas.
Yamashiro DJ; Nakagawara A; Ikegaki N; Liu XG; Brodeur GM
Oncogene; 1996 Jan; 12(1):37-41. PubMed ID: 8552397
[TBL] [Abstract][Full Text] [Related]
53. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma.
Nakagawara A; Arima-Nakagawara M; Scavarda NJ; Azar CG; Cantor AB; Brodeur GM
N Engl J Med; 1993 Mar; 328(12):847-54. PubMed ID: 8441429
[TBL] [Abstract][Full Text] [Related]
54. High Skp2 expression characterizes high-risk neuroblastomas independent of MYCN status.
Westermann F; Henrich KO; Wei JS; Lutz W; Fischer M; König R; Wiedemeyer R; Ehemann V; Brors B; Ernestus K; Leuschner I; Benner A; Khan J; Schwab M
Clin Cancer Res; 2007 Aug; 13(16):4695-703. PubMed ID: 17652624
[TBL] [Abstract][Full Text] [Related]
55. Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas.
Suzuki T; Bogenmann E; Shimada H; Stram D; Seeger RC
J Natl Cancer Inst; 1993 Mar; 85(5):377-84. PubMed ID: 8433391
[TBL] [Abstract][Full Text] [Related]
56. Induction of transforming growth factor beta 1 and its receptors during all-trans-retinoic acid (RA) treatment of RA-responsive human neuroblastoma cell lines.
Cohen PS; Letterio JJ; Gaetano C; Chan J; Matsumoto K; Sporn MB; Thiele CJ
Cancer Res; 1995 Jun; 55(11):2380-6. PubMed ID: 7757990
[TBL] [Abstract][Full Text] [Related]
57. Suppression of tubulin detyrosination by parthenolide recruits the plant-specific kinesin KCH to cortical microtubules.
Schneider N; Ludwig H; Nick P
J Exp Bot; 2015 Apr; 66(7):2001-11. PubMed ID: 25779700
[TBL] [Abstract][Full Text] [Related]
58. Evidence for new C-terminally truncated variants of α- and β-tubulins.
Aillaud C; Bosc C; Saoudi Y; Denarier E; Peris L; Sago L; Taulet N; Cieren A; Tort O; Magiera MM; Janke C; Redeker V; Andrieux A; Moutin MJ
Mol Biol Cell; 2016 Feb; 27(4):640-53. PubMed ID: 26739754
[TBL] [Abstract][Full Text] [Related]
59. Expression of neuronal src mRNA as a favorable marker and inverse correlation to N-myc gene amplification in human neuroblastomas.
Matsunaga T; Shirasawa H; Tanabe M; Ohnuma N; Kawamura K; Etoh T; Takahashi H; Simizu B
Int J Cancer; 1994 Sep; 58(6):793-8. PubMed ID: 7523310
[TBL] [Abstract][Full Text] [Related]
60. Prognostic value of TrkA protein detection by monoclonal antibody 5C3 in neuroblastoma.
Kramer K; Gerald W; LeSauteur L; Uri Saragovi H; Cheung NK
Clin Cancer Res; 1996 Aug; 2(8):1361-7. PubMed ID: 9816308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
